X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-04 | NVCR | Weinberg Uri | Chf Medical, Innovation Ofr | S - Sale+OE | $13.31 | -6,412 | 267,190 | -2% | -$85,314 | |||||
| M | 2026-02-27 | NVCR | Weinberg Uri | Chf Medical, Innovation Ofr | S - Sale | $13.68 | -10,733 | 223,477 | -5% | -$146,863 | |||||
2025-03-03 | NVCR | Weinberg Uri | Chief Innovation Officer | S - Sale | $18.92 | -268 | 166,243 | 0% | -$5,071 | ||||||
| A | 2025-02-28 | NVCR | Weinberg Uri | Chief Innovation Officer | S - Sale | $18.75 | -4,637 | 166,511 | -3% | -$86,949 | |||||
2025-02-28 | NVCR | Weinberg Uri | Chief Innovation Officer | S - Sale | $18.75 | -4,637 | 166,511 | -3% | -$86,949 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |